Commentary|Podcasts|January 20, 2025
Reaching Diverse Patient Populations With Personalized Treatment Methods
Author(s)Andy Studna, Senior Editor
Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses:
- Industry’s greatest challenges in reaching diverse patient populations
- Personalized treatment methods
- Recruitment strategies
- and more!
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
Women as the Missing Voice in Parkinson’s Disease
2
FDA Issues Draft Guidance to Advance Bayesian Methods in Clinical Trials
3
ACT Brief: AI Extends Trial Registries, Contract Bottlenecks Delay Activation, and Data Integration Pushes Integrated Care
4
Rethinking Site Activation to Cut Startup Timelines
5